JPY 2192.0
(0.41%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 150.53 Billion JPY | 11.48% |
2022 | 135.03 Billion JPY | 8.65% |
2021 | 124.28 Billion JPY | 1.99% |
2020 | 121.85 Billion JPY | 17.0% |
2019 | 104.15 Billion JPY | -5.68% |
2018 | 110.43 Billion JPY | -4.87% |
2017 | 116.08 Billion JPY | 1.51% |
2016 | 114.35 Billion JPY | -4.04% |
2015 | 119.17 Billion JPY | 23.8% |
2014 | 96.26 Billion JPY | -3.24% |
2013 | 99.49 Billion JPY | 27.15% |
2012 | 78.24 Billion JPY | 4.05% |
2011 | 75.2 Billion JPY | 1.93% |
2010 | 73.77 Billion JPY | 3.96% |
2009 | 70.97 Billion JPY | 22.13% |
2008 | 58.11 Billion JPY | 2.99% |
2007 | 56.42 Billion JPY | -3.58% |
2006 | 58.51 Billion JPY | 3.5% |
2005 | 56.53 Billion JPY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 152.11 Billion JPY | 1.05% |
2023 Q4 | 150.53 Billion JPY | -1.66% |
2023 Q3 | 153.06 Billion JPY | 3.31% |
2023 Q2 | 148.15 Billion JPY | 6.53% |
2023 FY | 150.53 Billion JPY | 11.48% |
2023 Q1 | 139.07 Billion JPY | 2.99% |
2022 Q3 | 137.07 Billion JPY | 1.99% |
2022 FY | 135.03 Billion JPY | 8.65% |
2022 Q4 | 135.03 Billion JPY | -1.49% |
2022 Q1 | 128.98 Billion JPY | 3.79% |
2022 Q2 | 134.4 Billion JPY | 4.2% |
2021 Q4 | 124.28 Billion JPY | -1.35% |
2021 Q1 | 123.11 Billion JPY | 1.03% |
2021 FY | 124.28 Billion JPY | 1.99% |
2021 Q3 | 125.98 Billion JPY | 1.87% |
2021 Q2 | 123.67 Billion JPY | 0.46% |
2020 Q2 | 106.37 Billion JPY | -0.35% |
2020 Q3 | 119.94 Billion JPY | 12.75% |
2020 Q4 | 121.85 Billion JPY | 1.6% |
2020 FY | 121.85 Billion JPY | 17.0% |
2020 Q1 | 106.75 Billion JPY | 2.49% |
2019 FY | 104.15 Billion JPY | -5.68% |
2019 Q4 | 104.15 Billion JPY | -4.28% |
2019 Q3 | 108.81 Billion JPY | 0.93% |
2019 Q2 | 107.8 Billion JPY | -2.08% |
2019 Q1 | 110.1 Billion JPY | -0.3% |
2018 Q2 | 113.36 Billion JPY | -0.77% |
2018 FY | 110.43 Billion JPY | -4.87% |
2018 Q1 | 114.24 Billion JPY | -1.58% |
2018 Q3 | 115.45 Billion JPY | 1.84% |
2018 Q4 | 110.43 Billion JPY | -4.35% |
2017 Q3 | 112.61 Billion JPY | -0.8% |
2017 Q1 | 111.89 Billion JPY | -2.15% |
2017 FY | 116.08 Billion JPY | 1.51% |
2017 Q4 | 116.08 Billion JPY | 3.08% |
2017 Q2 | 113.51 Billion JPY | 1.45% |
2016 FY | 114.35 Billion JPY | -4.04% |
2016 Q2 | 112.23 Billion JPY | -5.22% |
2016 Q1 | 118.41 Billion JPY | -0.64% |
2016 Q3 | 112.8 Billion JPY | 0.51% |
2016 Q4 | 114.35 Billion JPY | 1.38% |
2015 Q1 | 90.69 Billion JPY | -5.79% |
2015 FY | 119.17 Billion JPY | 23.8% |
2015 Q4 | 119.17 Billion JPY | 0.13% |
2015 Q3 | 119.02 Billion JPY | 3.72% |
2015 Q2 | 114.75 Billion JPY | 26.54% |
2014 Q4 | 96.26 Billion JPY | 1.94% |
2014 Q2 | 96.25 Billion JPY | 0.5% |
2014 Q3 | 94.43 Billion JPY | -1.89% |
2014 FY | 96.26 Billion JPY | -3.24% |
2014 Q1 | 95.78 Billion JPY | -3.73% |
2013 FY | 99.49 Billion JPY | 27.15% |
2013 Q1 | 77.48 Billion JPY | -0.98% |
2013 Q2 | 80.51 Billion JPY | 3.91% |
2013 Q3 | 85.84 Billion JPY | 6.62% |
2013 Q4 | 99.49 Billion JPY | 15.9% |
2012 Q1 | 76.12 Billion JPY | 1.23% |
2012 FY | 78.24 Billion JPY | 4.05% |
2012 Q4 | 78.24 Billion JPY | 1.92% |
2012 Q3 | 76.76 Billion JPY | 2.85% |
2012 Q2 | 74.64 Billion JPY | -1.95% |
2011 Q1 | 75.68 Billion JPY | 2.58% |
2011 Q2 | 75.77 Billion JPY | 0.12% |
2011 Q4 | 75.2 Billion JPY | -1.32% |
2011 FY | 75.2 Billion JPY | 1.93% |
2011 Q3 | 76.2 Billion JPY | 0.58% |
2010 Q3 | 75.76 Billion JPY | 2.9% |
2010 FY | 73.77 Billion JPY | 3.96% |
2010 Q2 | 73.63 Billion JPY | 8.92% |
2010 Q1 | 67.6 Billion JPY | -4.75% |
2010 Q4 | 73.77 Billion JPY | -2.62% |
2009 Q3 | 70.78 Billion JPY | -0.59% |
2009 Q4 | 70.97 Billion JPY | 0.26% |
2009 Q2 | 71.2 Billion JPY | 0.0% |
2009 FY | 70.97 Billion JPY | 22.13% |
2008 Q3 | 60.24 Billion JPY | 0.0% |
2008 Q4 | 58.11 Billion JPY | -3.55% |
2008 FY | 58.11 Billion JPY | 2.99% |
2007 FY | 56.42 Billion JPY | -3.58% |
2006 FY | 58.51 Billion JPY | 3.5% |
2005 FY | 56.53 Billion JPY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -311.598% |
Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.004% |
Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 83.412% |
Shionogi & Co., Ltd. | 1416.91 Billion JPY | 89.376% |
Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -876.156% |
Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 42.851% |
Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 12.288% |
Eisai Co., Ltd. | 1393.79 Billion JPY | 89.2% |
Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -776.061% |
Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 54.214% |
Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 5.206% |
Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -96.879% |
Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -203.814% |
Tsumura & Co. | 428.25 Billion JPY | 64.849% |
Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 42.309% |
Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | -12.817% |
Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 65.045% |
Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -76.409% |
KYORIN Holdings, Inc. | 177.67 Billion JPY | 15.278% |
Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -900.489% |
Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -93.717% |
SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -880.544% |
MedRx Co., Ltd | 2.05 Billion JPY | -7235.945% |
Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -694.443% |
Solasia Pharma K.K. | 2.55 Billion JPY | -5803.278% |
Modalis Therapeutics Corporation | 2.02 Billion JPY | -7330.364% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -61.323% |
Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 60.596% |
Cyfuse Biomedical K.K. | 4.21 Billion JPY | -3471.54% |
Toho Holdings Co., Ltd. | 773.42 Billion JPY | 80.537% |
Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -370.358% |